Pnc Financial Services Group, Inc. Nuvation Bio Inc. Transaction History
Pnc Financial Services Group, Inc.
- $150 Billion
- Q2 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 7,000 shares of NUVB stock, worth $15,470. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,000
Previous 7,114
1.6%
Holding current value
$15,470
Previous $25,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NUVB
# of Institutions
152Shares Held
123MCall Options Held
9.7KPut Options Held
6.5K-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$42.5 Million1.98% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$35.9 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.3MShares$29.3 Million50.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$22.4 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA6.95MShares$15.4 Million6.22% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $480M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...